Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.

NCT03220425 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

752

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Insulin detemir
DRUG: NPH insulin

Sponsor

Novo Nordisk A/S